Opinion
1don MSNOpinion
Her doctor recommended this cancer drug. Her insurance company denied it | Opinion
"Now, the person making the call is somebody somewhere who works for (the insurance company). It's not my physician, who's an expert." | Opinion ...
SkinCure Oncology, the industry leader in providing a comprehensive cancer center model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of ...
2026 CMS Physician Fee Schedule Final Rule provides a 300% per-fraction increase to delivery code that became effective January 1, 2026 Company enters 2026 with reimbursement certainty and strategic ...
“Following the publication of Current Procedural Terminology (CPT) codes for treating non-melanoma skin cancer with SRT in November – with a per-fraction increase of more than 300% versus prior ...
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...
Car enthusiast ThatDudeInBlue reviews the Dodge Durango SRT and calls it a hilarious 475HP grocery getter. Catherine O'Hara's cause of death revealed Gabbard's office warns attorney against sharing ...
Surgery is usually the main treatment for basal cell carcinoma and squamous cell carcinoma as well as most types of melanoma. Other times, surgery is used together with other treatment types.
For people not responding to a type of cancer treatment, a faecal transplant from someone who had success with the drug could boost their odds. Altering the gut microbiome has knock-on effects on the ...
Reservations open next month for free skin cancer screenings through Penn State Health Dermatology at its Lime Spring Outpatient Center in East Hempfield Township. An annual event for more than 25 ...
A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, ...
A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin cancer after five years, new data confirming its prolonged benefit show.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results